Amersfoort, J., Kuiper, J., & Bot, I. (2018). Reply to "Lipocalin-2 contributes to experimental atherosclerosis in a stage-dependent manner". Atherosclerosis (00219150), 278, 323. https://doi.org/10.1016/j.atherosclerosis.2018.08.024
Chicago Style (17th ed.) CitationAmersfoort, J., J. Kuiper, and I. Bot. "Reply to "Lipocalin-2 Contributes to Experimental Atherosclerosis in a Stage-dependent Manner"." Atherosclerosis (00219150) 278 (2018): 323. https://doi.org/10.1016/j.atherosclerosis.2018.08.024.
MLA (9th ed.) CitationAmersfoort, J., et al. "Reply to "Lipocalin-2 Contributes to Experimental Atherosclerosis in a Stage-dependent Manner"." Atherosclerosis (00219150), vol. 278, 2018, p. 323, https://doi.org/10.1016/j.atherosclerosis.2018.08.024.